Efficacy of Surufatinib in Western Patients (pts) with Pancreatic Neuroendocrine Tumors (PanNETs)

被引：0
|
作者：
Dasari, A. [1 ]
Paulson, S. [2 ]
Sung, M. [3 ]
Tucci, C. [4 ]
Kauh, J. [4 ]
Kania, M. [4 ]
Li, D. [5 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Baylor Charles A Sammons Canc Ctr Texas Oncol, Dallas, TX USA
[3] Mt Sinai Hosp, New York, NY USA
[4] Hutchison MediPharma Int Inc, Florham Pk, NJ USA
[5] City Hope Canc Ctr, Duarte, CA USA
来源：
NEUROENDOCRINOLOGY | 2020年 / 110卷
关键词：
neuroendocrine tumors; pancreatic; surufatinib;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
I02
引用
收藏
页码：209 / 209
页数：1
相关论文
共 50 条
  • [21] Treatment Options for Pancreatic Neuroendocrine Tumors
    Akirov, Amit
    Larouche, Vincent
    Alshehri, Sameerah
    Asa, Sylvia L.
    Ezzat, Shereen
    CANCERS, 2019, 11 (06)
  • [22] Role of everolimus in pancreatic neuroendocrine tumors
    Goldstein, Robert
    Meyer, Tim
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (11) : 1653 - 1665
  • [23] Biomarkers for prognosis in pancreatic neuroendocrine tumors
    Zhu, Mojun
    Sorenson, Karl R.
    Liu, Rebecca
    Rothberg, Bonnie E. Gould
    Halfdanarson, Thorvardur R.
    ENDOCRINE-RELATED CANCER, 2021, 28 (12) : 773 - 782
  • [24] Updates in the Diagnosis of Pancreatic Neuroendocrine Tumors
    Anton, C.
    Didita, A.
    Pantaze, A.
    Hartie, C.
    Haliga, R.
    Anton, E.
    PROCEEDINGS OF THE 49TH ANNUAL SCIENTIFIC MEETING OF THE EUROPEAN SOCIETY FOR CLINICAL INVESTIGATION, 2015, : 13 - 16
  • [25] PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
    Belotto, Marcos
    Santos Crouzillard, Bruna do Nascimento
    Araujo, Karla de Oliveira
    Peixoto, Renata D'Alpino
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2019, 32 (01):
  • [26] Safety Profile and Adverse Events of Special Interest for Surufatinib in Chinese Patients with Advanced Extra-Pancreatic Neuroendocrine Tumors: Analysis of the Phase 3 SANET-ep Trial
    Li, J.
    Xu, J.
    Zhou, Z.
    Bai, C.
    Chi, Y.
    Li, Z.
    Xu, N.
    Li, E.
    Liu, T.
    Bai, Y.
    Guan, S.
    Shen, L.
    NEUROENDOCRINOLOGY, 2020, 110 : 213 - 213
  • [27] A Lymph Node Ratio Model for Prognosis of Patients with Pancreatic Neuroendocrine Tumors
    Osher, Esther
    Shalabna, Eiman
    Klausner, Joseph M.
    Greenman, Yona
    Stern, Naftali
    Shibolet, Oren
    Scapa, Erez
    Yakir, Oz
    Shor, Dana Ben-Ami
    Bar-Yishay, Iddo
    Shamai, Sivan
    Sofer, Yael
    Lubezky, Nir
    Goykhman, Yaacov
    Lahat, Guy
    Wolf, Ido
    Pelles, Sharon
    Aizic, Asaf
    Blachar, Arye
    Geva, Ravit
    BIOMEDICINES, 2023, 11 (02)
  • [28] Long-Term Everolimus Treatment of Patients with Pancreatic Neuroendocrine Tumors
    Wolin, Edward M.
    CHEMOTHERAPY, 2014, 60 (03) : 143 - 150
  • [29] Simultaneous Resection of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases: Safety and Oncological Efficacy
    Addeo, Pietro
    Cusumano, Caterina
    Goichot, Bernard
    Guerra, Martina
    Faitot, Francois
    Imperiale, Alessio
    Bachellier, Philippe
    CANCERS, 2022, 14 (03)
  • [30] Comparative efficacy of Surufatinib plus trans arterial embolisation versus Surufatinib monotherapy in neuroendocrine tumor with liver metastasis: A prospective, randomised, controlled trial
    Li, X.
    Li, R.
    Cheng, K.
    Cao, D.
    JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 242 - 242
12345